Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 4.82B P/E 15.03 EPS this Y - Ern Qtrly Grth -13.50%
Income 4.87B Forward P/E - EPS next Y - 50D Avg Chg 11.00%
Sales 42.7B PEG - EPS past 5Y - 200D Avg Chg 20.00%
Dividend 30.00% Price/Book 0.06 EPS next 5Y - 52W High Chg -1.00%
Recommedations - Quick Ratio 1.09 Shares Outstanding 444.24M 52W Low Chg 46.00%
Insider Own - ROA 4.10% Shares Float 278.49M Beta 0.75
Inst Own - ROE 6.05% Shares Shorted/Prior -/- Price 10.82
Gross Margin 45.00% Profit Margin 11.40% Avg. Volume 238 Target Price -
Oper. Margin 16.56% Earnings Date Mar 5 Volume 48 Change 0.00%
About ASPEN PHARMACARE HLDGS UNSP ADR

Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and supplies specialty and branded pharmaceutical products worldwide. It operates in Commercial Pharmaceuticals and Manufacturing segments. The company provides general anesthetics, muscle relaxants, and topical agents under the Anaesthetics brand; and a range of injectable anticoagulants with a focus on low molecular weight heparins, Xa inhibitors, and heparin derivatives under the Thrombosis brand. It also offers branded consumer, prescription, and over-the-counter products under the regional brands, such as Circadin, Foxair, Maltofer, Mybulen, and Zyloric for various types of anesthetic comprises sleeping aid, respiratory, iron supplement, analgesic, and uric acid production inhibitor. In addition, the company manufactures and sells active pharmaceutical ingredients and finished dose form products to third-party customers. Aspen Pharmacare Holdings Limited was founded in 1850 and is headquartered in Durban, South Africa.